BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12055224)

  • 21. Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity.
    Ozawa H; Ding W; Torii H; Hosoi J; Seiffert K; Campton K; Hackett NR; Topf N; Crystal RG; Granstein RD
    J Invest Dermatol; 1999 Dec; 113(6):999-1005. PubMed ID: 10594743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
    Atarashi K; Kabashima K; Akiyama K; Tokura Y
    Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of tumor antigen presentation by urocanic acid.
    Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD
    J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects.
    Asahina A; Moro O; Hosoi J; Lerner EA; Xu S; Takashima A; Granstein RD
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8323-7. PubMed ID: 7667288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin gene-related peptide and Langerhans cell function.
    Torii H; Hosoi J; Asahina A; Granstein RD
    J Investig Dermatol Symp Proc; 1997 Aug; 2(1):82-6. PubMed ID: 9487021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity.
    Wang B; Feliciani C; Howell BG; Freed I; Cai Q; Watanabe H; Sauder DN
    J Immunol; 2002 Apr; 168(7):3303-8. PubMed ID: 11907086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75.
    Wang B; Fujisawa H; Zhuang L; Kondo S; Shivji GM; Kim CS; Mak TW; Sauder DN
    J Immunol; 1997 Dec; 159(12):6148-55. PubMed ID: 9550416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity.
    Girolomoni G; Pastore S; Zacchi V; Cavani A; Marconi A; Giannetti A
    J Immunol; 1993 May; 150(10):4236-43. PubMed ID: 8482834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Beissert S; Granstein RD
    J Leukoc Biol; 1994 Jun; 55(6):695-701. PubMed ID: 8195694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.
    Kurimoto I; Grammer SF; Shimizu T; Nakamura T; Streilein JW
    Immunology; 1995 Aug; 85(4):621-9. PubMed ID: 7558158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen presentation by epidermal Langerhans cells in experimental cutaneous leishmaniasis.
    Axelrod O; Klaus S; Frankenburg S
    Parasite Immunol; 1994 Nov; 16(11):593-8. PubMed ID: 7862465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCCTC-binding factor controls the homeostatic maintenance and migration of Langerhans cells.
    Kim TG; Kim M; Lee JJ; Kim SH; Je JH; Lee Y; Song MJ; Choi Y; Chung YW; Park CG; Cho JW; Lee MG; Lee YS; Kim HP
    J Allergy Clin Immunol; 2015 Sep; 136(3):713-24. PubMed ID: 25936568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of neuropeptides/hormones on Langerhans cells.
    Torii H; Tamaki K; Granstein RD
    J Dermatol Sci; 1998 May; 20(1):21-8. PubMed ID: 10342745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roxithromycin down-modulates antigen-presenting and interleukin-1 beta-producing abilities of murine Langerhans cells.
    Ohshima A; Tokura Y; Wakita H; Furukawa F; Takigawa M
    J Dermatol Sci; 1998 Jul; 17(3):214-22. PubMed ID: 9697050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of skin norepinephrine turnover by allergen sensitization: impact on contact hypersensitivity and T helper priming.
    Maestroni GJ
    J Invest Dermatol; 2004 Jan; 122(1):119-24. PubMed ID: 14962099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells.
    Sullivan S; Bergstresser PR; Tigelaar RE; Streilein JW
    J Immunol; 1986 Oct; 137(8):2460-7. PubMed ID: 2876041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.
    Halliday GM; Lucas AD
    Immunology; 1993 Aug; 79(4):621-6. PubMed ID: 8406587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells.
    Katayama I; Matsunaga T; Yokozeki H; Nishioka K
    Br J Dermatol; 1997 Jun; 136(6):846-52. PubMed ID: 9217815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin.
    Enk AH; Angeloni VL; Udey MC; Katz SI
    J Immunol; 1993 May; 150(9):3698-704. PubMed ID: 8473727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.